Pediatrix Medical reports Q4 adjusted EPS 50c, consensus 54c

Reports Q4 revenue $494M, consensus $486.23M. “Our fourth quarter operating results were in line with our revised upward expectations and reflected solid same-unit revenue growth, partially offset by an increase in variable practice incentive compensation,” said Mark Ordan, CEO of Pediatrix Medical (MD) Group. “Our performance in the fourth quarter caps a terrific year, and while facing healthcare industry headwinds, we are doing all we can to have another strong year at Pediatrix and to position ourselves for a strong future.”